Developing Biological Markers to Improve Clinical Care in Autism

Tuesday, February 13, 2024
Developing Biological Markers to Improve Clinical Care in Autism
Register Today

There is a critical need for objective biological measures to inform clinical practice and research in autism. Dr. McPartland will review the state of the science and present work from the Autism Biomarkers Consortium for Clinical Trials to advance biomarkers through FDA qualification. He will present emerging strategies to apply them in individuals with profound autism and to translate them into treatment.

Please use #BBRFWebinar when sharing or posting about our Meet the Scientist Webinars on social media.

Sign up for other upcoming webinars.

View past webinar recordings.

Presented by 
James McPartland, Ph.D.
James McPartland, Ph.D.

Harris Professor of Child Psychiatry and Psychology

Director, Yale Developmental Disabilities Clinic

Director, Yale Center for Brain and Mind Health

Yale School of Medicine

2009 Young Investigator Grant
 

James McPartland, Ph.D., is the Harris Professor of Child Psychiatry and Psychology at the Yale Child Study Center. He is a neuroscientist and practicing child psychologist who directs the Yale Developmental Disabilities Clinic. Dr. McPartland is also a founder and director of the Yale Center for Brain and Mind Health and the Principal Investigator of the Autism Biomarkers Consortium for Clinical Trials, a US-based effort to identify biological indices to enhance intervention research in autism. Dr. McPartland’s program of research investigates the brain bases of neurodevelopmental conditions to develop biologically-based tools to improve clinical care and quality of life for autistic people and their families.

Moderated by 
Jeffrey Borenstein, M.D.
Read Full Bio
Jeffrey Borenstein, M.D.
Brain & Behavior Research Foundation

President and CEO
 

Jeffrey Borenstein, M.D., serves as the President & CEO of the Brain & Behavior Research Foundation, the largest private funder of mental health research grants. Dr. Borenstein developed the Emmy-nominated public television program “Healthy Minds,” and serves as host and executive producer of the series. The program, broadcast nationwide, is available online, and focuses on topics in psychiatry in order to educate the public, reduce stigma and offer a message of hope. Dr. Borenstein also serves as Editor-in-Chief of Psychiatric News, the newspaper of the American Psychiatric Association.

Dr. Borenstein is a Fellow of the New York Academy of Medicine and serves as the Chair of the Section of Psychiatry at the Academy. He also has served as the President of the New York State Psychiatric Association. Dr. Borenstein earned his undergraduate degree at Harvard and his medical degree at New York University.